Safety and efficacy of HB0025, an anti-PD-1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: Preliminary results from an FIH trial.

Yiqun Du, Jiangfeng Li, Meili Sun et al.|Journal of Clinical Oncology|2023

Cited by 7